{"id":"https://openalex.org/W4387424834","doi":"https://doi.org/10.1016/j.htct.2023.09.026","title":"REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WITH AT LEAST ONE PRIOR THERAPY IN TURKEY","display_name":"REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WITH AT LEAST ONE PRIOR THERAPY IN TURKEY","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4387424834","doi":"https://doi.org/10.1016/j.htct.2023.09.026"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2023.09.026","doi":"https://doi.org/10.1016/j.htct.2023.09.026","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2023.09.026","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1016/j.htct.2023.09.026","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020093561","display_name":"\u00d6zg\u00fcr Pekta\u015f","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139898","display_name":"Sanofi (Turkey)","ror":"https://ror.org/040k92z84","country_code":"TR","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210139898"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ozgur Pektas","raw_affiliation_strings":["Sanofi, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Istanbul, Turkey","institution_ids":["https://openalex.org/I4210139898"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088369935","display_name":"Prakash Navaratnam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prakash Navaratnam","raw_affiliation_strings":["DataMed Solutions LLC, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DataMed Solutions LLC, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007269025","display_name":"Tanvi Rajput","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138224","display_name":"Sanofi (India)","ror":"https://ror.org/043zsj038","country_code":"IN","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138224"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Tanvi Rajput","raw_affiliation_strings":["Sanofi, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Hyderabad, Telangana, India","institution_ids":["https://openalex.org/I4210138224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073126467","display_name":"Howard Steven Friedman","orcid":"https://orcid.org/0000-0002-3528-5136","observed_orcids":["https://orcid.org/0000-0002-3528-5136","https://orcid.org/0000-0003-0568-546X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Howard S. Fr\u0131edman","raw_affiliation_strings":["DataMed Solutions LLC, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DataMed Solutions LLC, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093021501","display_name":"Ece Dem\u0131rk\u0131r","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139898","display_name":"Sanofi (Turkey)","ror":"https://ror.org/040k92z84","country_code":"TR","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210139898"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ece Dem\u0131rk\u0131r","raw_affiliation_strings":["Sanofi, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Istanbul, Turkey","institution_ids":["https://openalex.org/I4210139898"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076345537","display_name":"Christina Tekle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina Tekle","raw_affiliation_strings":["Sanofi, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107479105","display_name":"Peggy L. Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peggy L\u0131n","raw_affiliation_strings":["Sanofi, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Cambridge, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.1965,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.54428304,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":"45","issue":null,"first_page":"S15","last_page":"S15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.7850000262260437},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.996999979019165},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.8679999709129333},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9629999995231628},{"id":"https://openalex.org/keywords/lenalidomide-refractory-disease","display_name":"lenalidomide-refractory disease","score":0.7929999828338623},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5870000123977661},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.5419999957084656},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.5419999957084656},{"id":"https://openalex.org/keywords/turkish-patients","display_name":"Turkish patients","score":0.5929999947547913},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6179999709129333},{"id":"https://openalex.org/keywords/stem-cell-transplantation","display_name":"stem cell transplantation","score":0.5649999976158142},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.35600000619888306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8426697254180908},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.6743856072425842},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6264719367027283},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.5714903473854065},{"id":"https://openalex.org/C2778524551","wikidata":"https://www.wikidata.org/wiki/Q7227206","display_name":"Pomalidomide","level":4,"score":0.4977779686450958},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4956918954849243},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.45106935501098633},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.4224388003349304},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4213881194591522},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3360007703304291},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.16580867767333984},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2023.09.026","doi":"https://doi.org/10.1016/j.htct.2023.09.026","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2023.09.026","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:e6e1b75716444406b7b7d81404ae6ab8","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e6e1b75716444406b7b7d81404ae6ab8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S15- (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2023.09.026","doi":"https://doi.org/10.1016/j.htct.2023.09.026","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2023.09.026","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387748517","https://openalex.org/W2889985121","https://openalex.org/W3081477337","https://openalex.org/W7108724049","https://openalex.org/W7171445901","https://openalex.org/W7154829150","https://openalex.org/W4387748788","https://openalex.org/W2985873699","https://openalex.org/W4405048444","https://openalex.org/W2442320152"],"abstract_inverted_index":{"Data":[0],"on":[1,194],"RW":[2,30],"treatment":[3,33,72,83,193],"patterns":[4],"and":[5,25,35,63,76,80,85,115,138,155,163,173,183,200,212,216,227,249,265,279],"outcomes":[6,36],"in":[7,124,152,171,238,247,252,263,293],"RRMM":[8,53,94,253,291],"Pts":[9,39,54,95,219,292],"who":[10,40,55],"received":[11,41,57],"at":[12,42,58],"least":[13,43,59],"one":[14,44,60],"prior":[15,45,61],"line":[16],"of":[17,128,158,192,218,270],"therapy":[18,246],"(LoT)":[19],"are":[20],"lacking":[21],"outside":[22],"the":[23,92,167,283],"US":[24],"Europe.":[26],"This":[27,48],"study":[28],"evaluated":[29],"clinical":[31,81,114],"characteristics,":[32,82],"patterns,":[34,84],"among":[37],"Turkish":[38],"MM-specific":[46,71],"therapy.":[47],"retrospective":[49],"chart":[50],"review":[51],"included":[52],"had":[56,220],"LoT":[62],"initiated":[64],"a":[65],"second-line":[66],"(2L)":[67,154],"or":[68,258],"third-line":[69],"(3L)":[70,157],"regimen":[73],"between":[74],"01-Jan-2015":[75],"31-Dec-2020.":[77],"Patients\u2019":[78],"demographics":[79],"overall":[86],"survival":[87],"(OS)":[88],"were":[89,121,142,150,181,185,235,242,261],"evaluated.":[90],"Of":[91],"107":[93],"initiating":[96],"2L":[97,172,195,211,264],"treatment,":[98],"91.6%":[99],"experienced":[100],"symptomatic":[101],"disease":[102,221,273],"[prominent":[103],"symptoms:":[104],"anemia":[105],"(71.0%);":[106],"bone":[107],"lesions":[108],"(53.3%)].":[109],"Table":[110],"1":[111],"presents":[112],"other":[113],"demographic":[116],"characteristics.":[117],"Bortezomib":[118],"(BOR)-based":[119],"regimens":[120,141,149,170,234,241,288],"most":[122,168],"used":[123,143,151,243],"first-line":[125],"(1L)":[126],"regardless":[127],"stem-cell":[129],"transplant":[130],"(SCT)":[131],"status":[132],"(SCT":[133],"induction:":[134],"68.7%;":[135],"non-SCT:":[136],"79.5%),":[137],"lenalidomide":[139],"(LEN-based":[140],"as":[144,244,250],"1L":[145,248],"maintenance":[146,245],"(40.3%).":[147],"LEN-free":[148,287],"58.1%":[153],"35.6%":[156],"Pts,":[159],"with":[160],"DVd":[161],"(29.5%)":[162],"DRd":[164],"(19.5%)":[165],"being":[166],"utilized":[169,237,262],"3L,":[174],"respectively":[175,230],"(Fig.":[176],"1).":[177],"In":[178],"total,":[179],"53.1%":[180],"LEN-retreated":[182],"30.8%":[184],"LEN-refractory.":[186],"The":[187,267],"median":[188,223],"(interquartile":[189],"range)":[190],"duration":[191,269],"[7.0":[196],"(6.0,":[197,203],"10.5)":[198],"months]":[199,205],"3L":[201,213],"[7.1":[202],"14.0)":[204],"was":[206,225],"short":[207,268],"(Table":[208,231],"2).":[209],"After":[210],"initiation,":[214],"57.9%":[215],"25.6%":[217],"progression;":[222],"OS":[224],"10.4":[226],"12.8":[228],"months,":[229],"3).":[232],"BOR-based":[233],"commonly":[236],"1L.":[239],"LEN-based":[240],"retreatment":[251],"Pts.":[254],"Newer":[255],"therapies":[256],"(Daratumumab-":[257],"Carfilzomib-based":[259],"regimens)":[260],"3L.":[266],"therapy,":[271],"high":[272,276],"progression":[274],"rate,":[275],"LEN":[277],"retreatment,":[278],"refractoriness":[280],"rates":[281],"indicate":[282],"need":[284],"for":[285,289],"new":[286],"treating":[290],"Turkey.":[294]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-10-08T00:00:00"}